U.S. government contributed research to a Gilead remdesivir patent — but didn't get credit

U.S. government contributed research to a Gilead remdesivir patent — but didn't get credit

The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit

By ED SILVERMAN

JOSH EDELSON/AFP VIA GETTY IMAGES

Two documents dating back to 2015 shed further light on the role the federal government played in discovering remdesivir and its use against coronaviruses.

READ MORE